4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-17-030401
CIK 0001328143operating
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:31 PM ET
Size
7.4 KB
Accession
0001209191-17-030401
Insider Transaction Report
Form 4
KING RICHARD
Chief Operating Officer
Transactions
- Award
Common Stock
2017-05-05+28,125→ 28,125 total - Award
Stock Option (Right to Buy)
2017-05-05+168,750→ 168,750 totalExercise: $17.40Exp: 2027-05-04→ Common Stock (168,750 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest 1/4th on each of June 20, 2018, June 20, 2019, June 20, 2020, and June 20, 2021.
- [F2]The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option shall vest on April 28, 2018, and the remaining shares will vest in equal monthly installments over the next 36 months.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:31 PM ET
- Size
- 7.4 KB